載入...
Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: a prospective study with focus on primary tumor sidedness
BACKGROUND: In a prospective study with long-term follow-up, we analyzed circulating T cell subsets in patients with metastatic colorectal cancer (mCRC) in the context of primary tumor sidedness, KRAS status, and clinical outcome. Our primary goal was to investigate whether baseline levels of circul...
Na minha lista:
| 發表在: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6631500/ https://ncbi.nlm.nih.gov/pubmed/31307428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5909-5 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|